CEO FR: New Technology Dear Term Paper

One factor that should also be considered is whether our competitors are using the same type of technology to their benefit, and even more importantly to our detriment. It should not be a purchase just to 'keep up with the Joneses" but if the technology is helping our competitor, perhaps it would help us as well. It would probably be best to keep in mind that our company is unique, but that does not mean that benefits of a new purchase such as this one would not help us...

...

Is the purchase going to assist in achieving the company's goals and objectives in a cost effect manner? If it is, then the purchase should be made. If it is not, then the company should move on to bigger and better things.
Sincerely;

Employee

Cite this Document:

"CEO FR New Technology Dear" (2007, December 14) Retrieved April 24, 2024, from
https://www.paperdue.com/essay/ceo-fr-new-technology-dear-33283

"CEO FR New Technology Dear" 14 December 2007. Web.24 April. 2024. <
https://www.paperdue.com/essay/ceo-fr-new-technology-dear-33283>

"CEO FR New Technology Dear", 14 December 2007, Accessed.24 April. 2024,
https://www.paperdue.com/essay/ceo-fr-new-technology-dear-33283

Related Documents
Market Driven Management
PAGES 75 WORDS 25695

Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while competing with other companies that manufacture products that treat similar afflictions and ailments. The complexities in drug research and development and regulations have created an industry that is subject to intense

Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AND PATENTS LEGISLATIVE INITIATIVES REGARDING DTC RECALLED and/or DEADLY DRUGS In order to provide the most efficient method of evaluation, the study will utilize existing stores of qualitative and quantitative data from reliable sources, such as U.S. Government statistical references, University studies, and the studies and publications of non-profit